fbpx
Fighting Blindness Canada research

Cone-Rod Dystrophy

A new company, Beacon Therapeutics, has launched with a focus on gene therapies for cone-rod dystrophy and X-linked retinitis pigmentosa. Beacon will undertake preclinical work on a potential gene therapy for cone-rod dystrophy caused by mutations in the CDHR1 gene.

This work was originally started by Dr. Robert MacLaren (University of Oxford) who is a co-founder and adviser to the company. If these studies are successful, Beacon hopes to move the CDHR1 gene therapy to a human clinical trial in the coming years. 

Featured Posts

EssilorLuxottica

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

Learn More
Vision Expo new logo

NOW Trend Showcase Submission Deadline Extended to January 2025 

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Read more
Eschenbach logo

Eschenbach Sponsored Two Visually Impaired Students to Attend Space Camp!

For the third year in a row, in a special giving-back initiative, Eschenbach Optik of America sponsored two visually impaired students to attend the Space Camp for Interested Visually Impaired Students (SCIVIS).

Read more
Voila November-December 2024 Etnia Barcelona CESC

Etnia Barcelona’s FW24 Men’s Collection Unleashes Creativity

The FW24 collection from Etnia Barcelona embodies a bold expression of creativity and style, featuring designs that blend vibrant colours like striking orange with high-quality materials such as metal.

Read more
Centre for Ocular Research & Education (CORE)

CORE Publishes “The Science of Myopia Control: What Every ECP Should Know”

Contact Lens Update Issue 81 Offers Guidance from Top Researchers & Clinicians

Read more
EssilorLuxottica

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

Learn More
Vision Expo new logo

NOW Trend Showcase Submission Deadline Extended to January 2025 

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Read More
Eschenbach logo

Eschenbach Sponsored Two Visually Impaired Students to Attend Space Camp!

For the third year in a row, in a special giving-back initiative, Eschenbach Optik of America sponsored two visually impaired students to attend the Space Camp for Interested Visually Impaired Students (SCIVIS).

Read More
Voila November-December 2024 Etnia Barcelona CESC

Etnia Barcelona’s FW24 Men’s Collection Unleashes Creativity

The FW24 collection from Etnia Barcelona embodies a bold expression of creativity and style, featuring designs that blend vibrant colours like striking orange with high-quality materials such as metal.

Read More
Centre for Ocular Research & Education (CORE)

CORE Publishes “The Science of Myopia Control: What Every ECP Should Know”

Contact Lens Update Issue 81 Offers Guidance from Top Researchers & Clinicians

Read More
EssilorLuxottica

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

Learn More
Vision Expo new logo

NOW Trend Showcase Submission Deadline Extended to January 2025 

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Read more
Eschenbach logo

Eschenbach Sponsored Two Visually Impaired Students to Attend Space Camp!

For the third year in a row, in a special giving-back initiative, Eschenbach Optik of America sponsored two visually impaired students to attend the Space Camp for Interested Visually Impaired Students (SCIVIS).

Read more
Voila November-December 2024 Etnia Barcelona CESC

Etnia Barcelona’s FW24 Men’s Collection Unleashes Creativity

The FW24 collection from Etnia Barcelona embodies a bold expression of creativity and style, featuring designs that blend vibrant colours like striking orange with high-quality materials such as metal.

Read more
Centre for Ocular Research & Education (CORE)

CORE Publishes “The Science of Myopia Control: What Every ECP Should Know”

Contact Lens Update Issue 81 Offers Guidance from Top Researchers & Clinicians

Read more
EssilorLuxottica

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

Learn More
Vision Expo new logo

NOW Trend Showcase Submission Deadline Extended to January 2025 

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Read more
Eschenbach logo

Eschenbach Sponsored Two Visually Impaired Students to Attend Space Camp!

For the third year in a row, in a special giving-back initiative, Eschenbach Optik of America sponsored two visually impaired students to attend the Space Camp for Interested Visually Impaired Students (SCIVIS).

Read more
Voila November-December 2024 Etnia Barcelona CESC

Etnia Barcelona’s FW24 Men’s Collection Unleashes Creativity

The FW24 collection from Etnia Barcelona embodies a bold expression of creativity and style, featuring designs that blend vibrant colours like striking orange with high-quality materials such as metal.

Read more
Centre for Ocular Research & Education (CORE)

CORE Publishes “The Science of Myopia Control: What Every ECP Should Know”

Contact Lens Update Issue 81 Offers Guidance from Top Researchers & Clinicians

Read more